| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6267423dbf5278a615914354092dcc0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d98762490c9bfd1551fefe55f49ea2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e5fb4e8398929381a1c66f4802b03d7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2017-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5669c5f6bc5518a939151a3b97a5352a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64bbbfa98e3227b8c04d1366034f4975
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e38a26e06ffbfe7e21df22decfff390
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5003962a6c48f763983c1a05788be4f5 |
| publicationDate |
2017-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20170115029-A |
| titleOfInvention |
Composotion comprising α1-antitrypsin inhibitor for preventing or treating lung cancer and biomarker composition for diagnosing comprising α1-antitrypsin |
| abstract |
The present invention relates to a composition for preventing or treating lung cancer comprising an alpha 1-antitrypsin inhibitor and a biomarker composition for diagnosing lung cancer comprising alpha 1-antitrypsin. The alpha-1-antitrypsin inhibitor according to the present invention can effectively prevent or treat lung cancer by inhibiting cell proliferation and tumor formation of lung cancer cells. In addition, the alpha-1-antitrypsin according to the present invention can be used for predicting or predicting the likelihood of developing lung cancer and disease severity, and can be used for the early diagnosis of lung cancer noninvasively. Therefore, And can be usefully used for tumor formation studies. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11254937-B2 |
| priorityDate |
2017-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |